Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (511-520 of 692) with videos related to

Pageof 70
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2015
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trialsK Fizazi, T W Flaig, M Stöckle, et al.
Neurology|May 24, 2013
Migraine, depression, and brain volume: the AGES-Reykjavik StudyLarus S Gudmundsson, Ann I Scher, Sigurdur Sigurdsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2013
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancerJorge A Carrasquillo, Joseph A O'Donoghue, Neeta Pandit-Taskar, et al.
The Journal of Clinical Investigation|March 4, 2010
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesisAndrea Alimonti, Caterina Nardella, Zhenbang Chen, et al.
Cancer Research|February 5, 2009
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomyAnuradha Gopalan, Margaret A Leversha, Jaya M Satagopan, et al.
Cephalalgia : an International Journal of Headache|March 22, 2024
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injuryHåkan Ashina, Hans-Christoph Diener, Cristina Tassorelli, et al.
The Journal of Headache and Pain|October 29, 2013
Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerationsTimothy J Steiner, Lars Jacob Stovner, Mohammed Al Jumah, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in manS F Slovin, G Ragupathi, S Adluri, et al.
JAMA Oncology|June 30, 2018
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2017
Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical TrialsGlenn Heller, Robert McCormack, Thian Kheoh, et al.
Pageof 70

Showing results (511-520 of 692) with videos related to

Sort By:
Pageof 70
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2015
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trialsK Fizazi, T W Flaig, M Stöckle, et al.
Neurology|May 24, 2013
Migraine, depression, and brain volume: the AGES-Reykjavik StudyLarus S Gudmundsson, Ann I Scher, Sigurdur Sigurdsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2013
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancerJorge A Carrasquillo, Joseph A O'Donoghue, Neeta Pandit-Taskar, et al.
The Journal of Clinical Investigation|March 4, 2010
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesisAndrea Alimonti, Caterina Nardella, Zhenbang Chen, et al.
Cancer Research|February 5, 2009
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomyAnuradha Gopalan, Margaret A Leversha, Jaya M Satagopan, et al.
Cephalalgia : an International Journal of Headache|March 22, 2024
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injuryHåkan Ashina, Hans-Christoph Diener, Cristina Tassorelli, et al.
The Journal of Headache and Pain|October 29, 2013
Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerationsTimothy J Steiner, Lars Jacob Stovner, Mohammed Al Jumah, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in manS F Slovin, G Ragupathi, S Adluri, et al.
JAMA Oncology|June 30, 2018
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2017
Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical TrialsGlenn Heller, Robert McCormack, Thian Kheoh, et al.
Pageof 70